Carmichael Hill & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $136K | Buy |
|
|||||
|
2024
Q2 | $162K | Hold |
|
|||||
|
2024
Q1 | $145K | Sell |
|
|||||
|
2023
Q4 | $148K | Hold |
|
|||||
|
2023
Q3 | $130K | Hold |
|
|||||
|
2023
Q2 | $116K | Sell |
|
|||||
|
2023
Q1 | $130K | Hold |
|
|||||
|
2022
Q4 | $110K | Hold |
|
|||||
|
2022
Q3 | $81K | Hold |
|
|||||
|
2022
Q2 | $91K | Hold |
|
|||||
|
2022
Q1 | $91K | Hold |
|
|||||
|
2021
Q4 | $91K | Hold |
|
|||||
|
2021
Q3 | $78K | Hold |
|
|||||
|
2021
Q2 | $68K | Buy |
|
|||||
|
2021
Q1 | $54K | Hold |
|
|||||
|
2020
Q4 | $56K | Hold |
|
|||||
|
2020
Q3 | $56K | Hold |
|
|||||
|
2020
Q2 | $53K | Hold |
|
|||||
|
2020
Q1 | $49K | Hold |
|
|||||
|
2019
Q4 | $47K | Buy |
|